Patient's Choice Act of 2024
If passed, SB3932 would maintain the current maximum duration for short-term limited duration insurance plans at up to 36 months, with the intention of preserving this form of insurance as a viable option for consumers who may be unable to afford traditional health insurance. The bill is significant as it amends title XXVII of the Public Health Service Act to provide a clearer definition of short-term limited duration insurance, distinguishing it from other forms of health coverage. The implications could potentially protect individuals seeking temporary coverage while ensuring that their options remain available without the interference of future regulations from the federal government.
Senate Bill 3932, titled the 'Patient’s Choice Act of 2024', seeks to prohibit the Secretary of Health and Human Services, the Secretary of Labor, and the Secretary of the Treasury from finalizing rules that would impose restrictions on short-term limited duration insurance. This legislation is a direct response to regulatory efforts aimed at reducing the maximum term length for such plans, which are often marketed as affordable alternatives to more comprehensive health insurance. As of this bill’s enactment, the existing rules regarding the duration of short-term plans would remain intact.
The bill has sparked debate among legislators and health advocates. Proponents argue that maintaining access to short-term plans is essential for individuals who need flexibility and affordable options in their health care coverage. Conversely, opponents raise concerns that such plans often provide inadequate coverage, may not meet the needs of consumers, and can contribute to rising healthcare costs overall by attracting healthier individuals away from comprehensive plans. This ongoing tension reflects a broader discussion regarding the direction of healthcare policy in the United States and the balance between consumer choice and regulatory oversight.